KR900701770A - 벤조 티아디아제핀 유도체 - Google Patents

벤조 티아디아제핀 유도체

Info

Publication number
KR900701770A
KR900701770A KR1019900701322A KR900701322A KR900701770A KR 900701770 A KR900701770 A KR 900701770A KR 1019900701322 A KR1019900701322 A KR 1019900701322A KR 900701322 A KR900701322 A KR 900701322A KR 900701770 A KR900701770 A KR 900701770A
Authority
KR
South Korea
Prior art keywords
methyl
ethyl
pharmaceutically acceptable
alkyl group
lower alkyl
Prior art date
Application number
KR1019900701322A
Other languages
English (en)
Inventor
가즈오 오가와
요오이찌 마쓰시다
Original Assignee
고바야시 유끼오
다이호오 야꾸힌 고오교오 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 고바야시 유끼오, 다이호오 야꾸힌 고오교오 가부시끼가이샤 filed Critical 고바야시 유끼오
Publication of KR900701770A publication Critical patent/KR900701770A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/36—Seven-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

내용 없음

Description

벤조 티아디아제핀 유도체
내용없음

Claims (5)

  1. 일반식
    [식중 R1은 저급 알킬기 또는 (R3는 수소원자, 저급 알콕시기 또는 할로겐 원자를 내고, 1개 또는 동일 혹은 상이한 2~3개 치환해도 좋다.)를 나타낸다. R2-(CH2)n
    또는 -(CH2)nCO2R8, n은 1~4의 정수로 R4및 R6는 동일 또는 상이한 수소 원자 또는 저급 알킬기를 나타낸다. 또 R4와 R6는 서로 결합해서 환상 구조를 형성하고 그 환상 구조 중에 다시 산소 원자 혹은 질소 원자를 포함하고 있어도 좋다, R8는 수소원자 또는 저급 알킬기를 나타낸다.]로 표시되는 벤조 티아디아제핀 유도체 및 그 약학적으로 허용되는 염.
  2. R1이 메틸, 벤질, 4-메톡시벤질, 4-클로르벤질, 2,4-디클로르벤질 또는 2-플루오로-4-부로모벤질, R2가 -(CH2)nNR4R6(여기에서 n은 2또는 3으로, R4및 R6는 동일 상이한 수소 원자 또는 저급 알킬기를 나타내거나, 또는 R4와 R6는 서로 결합해서 질소 원자와 함께 피롤리딘, 파레리딘, 몰포린, N메틸피레라진, 4-히드록시 피레리딘환을 형성한다, CH2CH(OH)CH2NR4R6(여기서 R4및 R6는 동일 또는 상이하며 수소 원자 또는 저급 알킬기를 나타내거나 또는 R4와 R6는 서로 결합해서 질소 원자와 함께 피롤리딘, 피페리딘, 몰포린, N-메틸 피레라진, 4-히드록시 피페리딘 환을 형성한다.) 또는 -CH2CON R4R6(여기에서 R4와 R6는 서로 결합해서 질소원자와 함께 피롤리딘, 피레리딘, 몰포린, N-메틸 피페라진, 4-히드록시 피페리딘 환을 형성한다) 또는 -CH2CON R4R6(여기에서 R4와 R6는 서로 결합해서 질소 원자와 함께 피롤리딘, 피페리딘, 몰포린, N-메틸 피페라진, 4-히드록시 피레리딘 환을 형성한다)로 표시되는 기인 청구 범위 제1항 기재의 벤조티아디아제핀 유도체 및 그 약학적으로 허용되는 염.
  3. R1이 메틸, 벤질, 4-메톡시 벤질, 또는 4-클로로벤질, R2가 디메틸아미노 에틸, 디메틸아미노프로필,(피롤라디노-1-일)에틸, (피페리디노-1-일)프로필, (몰포리노-1-일)에틸, (몰포리노-1-일)프로필, (4-메틸 피레라지노-1-일)프로필 [2-옥소-2-(몰포리노-1-일)]에틸, [2-옥소-2-(4-메틸 피페라디노-1-일)]에틸 또는 [2-옥소-2-(피페리디노-1-일)]에틸인 청구의 범위 제2항 기재의 벤조티아디아제핀 유도체 및 그 약학적으로 허용되는 염.
  4. 청구범위 제1항 기재의 벤조티아디아제핀 유도체 또는 그 약학적으로 허용되는 염의 유효량과 약학적으로 허용되는 담체 또는 부형제를 함유하는 항 부정맥제.
  5. 청구 범위 제4항 기재의 항 부정맥제를 환자에 투여하는 것을 특징으로 하는 항 부정맥 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019900701322A 1988-10-20 1989-10-18 벤조 티아디아제핀 유도체 KR900701770A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP63264702A JPH02111766A (ja) 1988-10-20 1988-10-20 ベンゾチアジアゼピン誘導体及びその塩
JP63-264702 1988-10-20
PCT/JP1989/001069 WO1990004590A1 (en) 1988-10-20 1989-10-18 Benzothiadiazepine derivatives

Publications (1)

Publication Number Publication Date
KR900701770A true KR900701770A (ko) 1990-12-04

Family

ID=17406997

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900701322A KR900701770A (ko) 1988-10-20 1989-10-18 벤조 티아디아제핀 유도체

Country Status (8)

Country Link
US (1) US5036065A (ko)
EP (1) EP0394484B1 (ko)
JP (1) JPH02111766A (ko)
KR (1) KR900701770A (ko)
AT (1) ATE118488T1 (ko)
AU (1) AU615589B2 (ko)
DE (1) DE68921198T2 (ko)
WO (1) WO1990004590A1 (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0918771A4 (en) 1996-07-15 2001-02-07 Bristol Myers Squibb Co THIADIOXOBENZODIAZEPINES FOR USE AS FARNESYL PROTEIN TRANSFERASE INHIBITORS
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
EP1889198B1 (en) 2005-04-28 2014-11-26 Proteus Digital Health, Inc. Pharma-informatics system
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
DK3395372T3 (da) 2009-02-20 2022-04-19 Enhanx Biopharm Inc System til afgivelse af glutathion-baseret medikament
EP2427178B1 (en) 2009-05-06 2023-01-04 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3453266A (en) * 1966-03-14 1969-07-01 American Home Prod 1,2,5-benzothiadiazepine 1,1-dioxides
JPS4643790B1 (ko) * 1969-01-23 1971-12-25
IT1225729B (it) * 1988-08-12 1990-11-26 Menarini S A S Firenze A Derivati della 5,5-diossido-6,11-diidrodibenzo (c,f)(1,2,5) tiadiazepina, loro sali e relativi procedimenti di fabbricazione

Also Published As

Publication number Publication date
AU615589B2 (en) 1991-10-03
JPH02111766A (ja) 1990-04-24
DE68921198T2 (de) 1995-09-28
DE68921198D1 (de) 1995-03-23
AU4411089A (en) 1990-05-14
US5036065A (en) 1991-07-30
WO1990004590A1 (en) 1990-05-03
ATE118488T1 (de) 1995-03-15
EP0394484A1 (en) 1990-10-31
EP0394484B1 (en) 1995-02-15
EP0394484A4 (en) 1991-07-17

Similar Documents

Publication Publication Date Title
DE68910210D1 (de) (1-Hydroxy-2-piperidinylalkyl)-2-indolon, 2-quinolinon, 2-benzo[b]azepinon, 2-benzimidazolon und 2-quinazolinon-Derivate, Verfahren zu ihrer Herstellung und ihre therapeutische Verwendung.
DE3681517D1 (de) Thiazolidinderivate, verfahren zu deren herstellung und deren anwendung.
HUT69686A (en) Process for preparing pharmaceutical compositions having serum cholesterol lowering effect
FI943142A0 (fi) Amidi- ja ureajohdannaiset, joilla on veren korkeita kolesteroliarvoja vastustava vaikutus, niiden valmistus ja terapeuttiset käytöt
NL180206C (nl) Verbinding en geneesmiddel met analgetische werking.
KR950010893A (ko) 자궁내막증 억제 방법
KR950010892A (ko) 자궁 섬유증 억제 방법
EA199700450A1 (ru) Способы подавления миграции сосудистых гладкомышечных клеток
ES2064461T3 (es) Derivados de xantina, procedimiento para su preparacion y composicion farmaceutica.
ATE205712T1 (de) Verwendung von 2-phenyl-3-aroylbenzothiophen derivaten zur herstellung eines medikaments zur hemmung der angiogenese und angiogene krankheiten
DE3788701D1 (de) Oxadiazolylalkylpurin-Derivate, ihre Herstellung und ihre Verwendung in pharmazeutischen Mitteln.
ATE199642T1 (de) Verwendung von 2-phenyl-3-aroylbenzothiophen derivaten zur herstellung eines medikaments zur hemmung des knorpelabbaus
DE69119875D1 (de) Verwendung von Dioxabicyclo [3.3.0]octane Derivaten zur Herstellung eines Arzneimittels zur Hemmung des Cholesterinmetabolismus.
KR900701770A (ko) 벤조 티아디아제핀 유도체
KR840006985A (ko) N-치환플라본-8-카르복사미드유도체 및 그 제조방법
ATE173252T1 (de) Arylmorpholine, herstellung und verwendung
ATE124408T1 (de) Heterozyklische aminderivate, deren herstellung und deren verwendung.
TW355183B (en) Substituted benzenesulfonylureas having cardiovascular activity for their preparation, and pharmaceutical compositions containing them
KR880007462A (ko) 빈뇨치료용 프로피오페논 유도체
HU893127D0 (en) Process for the preparation of novel spiro-(imidazolidino-naphtaline) derivatives and pharmaceutical compositions containing such compounds as active ingredient
KR960003719A (ko) 녹내장 치료제 및 안압 강하제
ATE179071T1 (de) Verwendung eines thioesters zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von ischämie und von reperfusion-syndromen
ATE63908T1 (de) 1,5-benzothiazepinderivate, deren herstellung und deren verwendung in der therapie.
ES2016305B3 (es) Compuestos de piperazina, procedimiento para prepararlos y composicion farmaceutica y su uso.
KR910002456A (ko) 당뇨병 치료용 제약 조성물

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee